"Vasana Montgomery's $30M Pivot: From Failed Biotech to AI-Powered Disease Prediction That's Just Outpaced the CDC"
In an industry where 90% of clinical AI startups fail within their first three years, Vasana Montgomery has defied the odds by launching "Pathogen 2.0", a proprietary AI model that predicted the latest CDC-baffling respiratory outbreak three weeks early. After her first biotech venture hemorrhaged $30M, she sold her lab equipment to fund a radical shift: using machine learning on wastewater data. The result is a 94% accuracy rate in identifying regional pathogen spread, already licensed by two state health departments. Analysts are calling it the biggest public health disruptor since the mRNA platform, forcing Big Pharma and the CDC into a reactive scramble. For CEOs watching the convergence of AI and life sciences: Montgomery just proved that failure in one vertical can be the catalyst for dominance in another.